SGMT

Sagimet Biosciences Inc. NGM · SGMT

$7.82 +0.17 (+2.22%)

Neutral · +0.88σ

+ Compare Open in Sniper

Valuation

Market cap $0.5B

P/E (ttm) —

Forward P/E -6.0

Beta (5y) 3.38

Shares out 61.2M

Div yield —

Profitability & returns

ROE -36.0%

Net margin —

FCF margin —

Debt / equity 0.00

Trading information

Last price $7.82

Day range $7.34 – $8.10

52-wk range $4.50 – $9.37

Avg volume 1.9M

RSI (2) 62.0

Trend zone Neutral

52-week range · today's price

$4.50$9.37

Company

Sector Healthcare

Industry Biotechnology

Exchange NGM

Next earnings 2026-08-12

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated stea…